In a recent study posted to the medRxiv preprint* server, researchers pursued evidence of whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens, of which spike (S) protein is ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Nearly 85% of people with long COVID had experienced ...

Research reveals a sharp decline in both the effectiveness and duration of protection from prior infection post-Omicron, underscoring the need for updated vaccines to sustain immunity Study: ...

Two of the closest known relatives to SARS-CoV-2 — a pair of bat coronaviruses discovered by researchers in Laos — may transmit poorly in people despite being genetically similar to the ...

Researchers have discovered that SARS-CoV-2 hijacks three important host proteins that dampen the activity of the complement system, a key component of early antiviral immunity. This significantly ...

UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...

By Hugo Francisco de Souza Detailed immune profiling in long-term care populations reveals that SARS-CoV-2 vaccines and ...

The World Health Organization (WHO) announced the prequalification of two rapid antigen diagnostic tests (Ag-RDT) for ...

In early 2020, multisystemic inflammatory syndrome in children (MIS-C) was recognized as an emerging life-threatening disease occurring 2 to 6 weeks after infection with severe acute respiratory ...